These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
328 related items for PubMed ID: 30380548
1. Angiotensin II Type I Receptor Agonistic Autoantibody Induces Podocyte Injury via Activation of the TRPC6- Calcium/Calcineurin Pathway in Pre-Eclampsia. Yu Y, Zhang L, Xu G, Wu Z, Li Q, Gu Y, Niu J. Kidney Blood Press Res; 2018; 43(5):1666-1676. PubMed ID: 30380548 [Abstract] [Full Text] [Related]
2. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury. Verheijden KAT, Sonneveld R, Bakker-van Bebber M, Wetzels JFM, van der Vlag J, Nijenhuis T. J Am Soc Nephrol; 2018 Aug; 29(8):2099-2109. PubMed ID: 29954830 [Abstract] [Full Text] [Related]
3. Angiotensin II induces calcium/calcineurin signaling and podocyte injury by downregulating microRNA-30 family members. Zhao Y, Wu J, Zhang M, Zhou M, Xu F, Zhu X, Zhou X, Lang Y, Yang F, Yun S, Shi S, Liu Z. J Mol Med (Berl); 2017 Aug; 95(8):887-898. PubMed ID: 28540409 [Abstract] [Full Text] [Related]
4. Tetrandrine Suppresses Transient Receptor Potential Cation Channel Protein 6 Overexpression- Induced Podocyte Damage via Blockage of RhoA/ROCK1 Signaling. Yu J, Zhu C, Yin J, Yu D, Wan F, Tang X, Jiang X. Drug Des Devel Ther; 2020 Aug; 14():361-370. PubMed ID: 32095070 [Abstract] [Full Text] [Related]
5. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. Nijenhuis T, Sloan AJ, Hoenderop JG, Flesche J, van Goor H, Kistler AD, Bakker M, Bindels RJ, de Boer RA, Möller CC, Hamming I, Navis G, Wetzels JF, Berden JH, Reiser J, Faul C, van der Vlag J. Am J Pathol; 2011 Oct; 179(4):1719-32. PubMed ID: 21839714 [Abstract] [Full Text] [Related]
6. RANK Deficiency Ameliorates Podocyte Injury by Suppressing Calcium/Calcineurin/ NFATc1 Signaling. Liang S, Zhang H, Du Y, Dou C, Liu S, Zhang L, Chen Y, Li R, Ma J, Li Z, Lin T, Zhao X, Zhang Q, Wang W, Ye Z, Liang X, Shi W, Zhang B. Kidney Blood Press Res; 2018 Oct; 43(4):1149-1159. PubMed ID: 30036881 [Abstract] [Full Text] [Related]
7. Angiotensin II type I receptor agonistic autoantibody-induced apoptosis in neonatal rat cardiomyocytes is dependent on the generation of tumor necrosis factor-α. Chai W, Zhang W, Jin Z, Feng Y, Kuang Y, Zhi J. Acta Biochim Biophys Sin (Shanghai); 2012 Dec; 44(12):984-90. PubMed ID: 23089979 [Abstract] [Full Text] [Related]
8. Complement Split Products C3a/C5a and Receptors: Are They Regulated by Circulating Angiotensin II Type 1 Receptor Autoantibody in Severe Preeclampsia? Ye Y, Kong Y, Zhang Y. Gynecol Obstet Invest; 2016 Dec; 81(1):28-33. PubMed ID: 26485247 [Abstract] [Full Text] [Related]
9. Autoantibody against angiotensin AT1 receptor from preeclamptic patients enhances collagen-induced human platelet aggregation. Bai K, Wang K, Li X, Wang J, Zhang J, Song L, Wang J, Zhang S, Lau WB, Ma X, Liu H. Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):749-55. PubMed ID: 23681235 [Abstract] [Full Text] [Related]
10. Calcium-Sensing Receptor Stimulation in Cultured Glomerular Podocytes Induces TRPC6-Dependent Calcium Entry and RhoA Activation. Zhang L, Ji T, Wang Q, Meng K, Zhang R, Yang H, Liao C, Ma L, Jiao J. Cell Physiol Biochem; 2017 Sep; 43(5):1777-1789. PubMed ID: 29050010 [Abstract] [Full Text] [Related]
11. Endothelin-1, oxidative stress, and endogenous angiotensin II: mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure response during pregnancy. Brewer J, Liu R, Lu Y, Scott J, Wallace K, Wallukat G, Moseley J, Herse F, Dechend R, Martin JN, Lamarca B. Hypertension; 2013 Nov; 62(5):886-92. PubMed ID: 24041954 [Abstract] [Full Text] [Related]
12. Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation. Yang X, Wang F, Chang H, Zhang S, Yang L, Wang X, Cheng X, Zhang M, Ma XL, Liu H. J Hypertens; 2008 Aug; 26(8):1629-35. PubMed ID: 18622242 [Abstract] [Full Text] [Related]
14. Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells. Xia Y, Wen H, Bobst S, Day MC, Kellems RE. J Soc Gynecol Investig; 2003 Feb; 10(2):82-93. PubMed ID: 12593997 [Abstract] [Full Text] [Related]
15. Klotho Stabilizes the Podocyte Actin Cytoskeleton in Idiopathic Membranous Nephropathy through Regulating the TRPC6/CatL Pathway. Wang H, Liu H, Cheng H, Xue X, Ge Y, Wang X, Yuan J. Am J Nephrol; 2024 Feb; 55(3):345-360. PubMed ID: 38330925 [Abstract] [Full Text] [Related]
16. Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner. Sonneveld R, van der Vlag J, Baltissen MP, Verkaart SA, Wetzels JF, Berden JH, Hoenderop JG, Nijenhuis T. Am J Pathol; 2014 Jun; 184(6):1715-26. PubMed ID: 24731445 [Abstract] [Full Text] [Related]
17. Angiotensin type 1 receptor autoantibody from preeclamptic patients induces human fetoplacental vasoconstriction. Zhang S, Zheng R, Yang L, Zhang X, Zuo L, Yang X, Bai K, Song L, Tian J, Yang J, Liu H. J Cell Physiol; 2013 Jan; 228(1):142-8. PubMed ID: 22566240 [Abstract] [Full Text] [Related]
18. Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation. Thway TM, Shlykov SG, Day MC, Sanborn BM, Gilstrap LC, Xia Y, Kellems RE. Circulation; 2004 Sep 21; 110(12):1612-9. PubMed ID: 15381659 [Abstract] [Full Text] [Related]